Mild hypoglycemia can produce symptoms that mimic anxiety, including shakiness and irritability
The court has not yet issued a schedule for bellwether trials, but early procedural groundwork remains ongoing
Sometimes, an underlying condition like hypothyroidism, polycystic ovary syndrome, or medication side effects from other drugs can limit the effectiveness of GLP-1 treatment
Email support states up front that it cannot answer health, diet, or medication questions and directs you to the in-app care coordinators
Progressing K-554, a potential first-in-class non-incretin peptide for metabolic disease, to Phase 1 studies, with early data expected H2 2026 Kallyope, a late-stage biotechnology company focused on developing innovative migraine and metabolic disease therapies for health challenges faced by hundreds of millions of people globally, announced the Companys strategic priorities for 2026
adults are considered overweight or obese, while about 12% have diabetes